CSIMarket
 


Singular Genomics Systems Inc   (OMIC)
Other Ticker:  
 


Singular Genomics Systems Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Singular Genomics Systems Inc's ROI in the third quarter of 2023?
Singular Genomics Systems Inc achieved a return on average invested assets (ROI) of 37.04 % in its third quarter of 2023, this is above OMIC's average return on investment of 7.78%.
Singular Genomics Systems Inc invested over the 12 months ending in its third quarter of 2023 $241 million

ROI has improved compared to 33.71% in the second quarter of 2023, due to net income growth.

Within the Healthcare sector 29 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2023 quarter, so far to 163, from total ROI ranking in the second quarter of 2023 at 183.

Definition and Formula of Return on Investment


Return On Investment (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Investment Change -27.1 % -25.7 % -23.61 % -22.21 % -
Y / Y Net Income Change - - - 191.63 % -
Investment (TTM) in Millions 210 229 251 271 288
Return On Investment (TTM) 37.04 % 33.71 % 31.89 % 30.36 % -4.61 %
OMIC's Overall Ranking # 163 # 183 # 220 # 217 # 0
Seq. Investment Change -8.47 % -8.77 % -7.36 % -5.76 % -6.71 %
Seq. Net Income Change - - - - -
Net Income (TTM) in Millions 89 88 89 91 -15




Return On Investment OMIC's Ranking
Within: No.
Industry # 1
Sector # 30
Overall # 163

Return On Investment Statistics
High Average Low
31.1 %
7.78 %
-39.89 %
(Sep 30 2023)   (Jun 30 2021)







Financial Statements
Singular Genomics Systems Inc's III. Quarter Investments $ 210 Millions OMIC's Balance sheet
Singular Genomics Systems Inc's III. Quarter Income $ -22 Millions Quarterly OMIC's Income Statement
OMIC's Income by Division See OMIC's Income by Division


OMIC Annual Return On Investment (Dec 31 2022)
2022
(Dec 31 2021)
2021



Total Investments in Millions 271 349 0 0 0
Y / Y Investment Growth -22.21 % - - - -
Net Income in Millions 91 -99 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 33.49 % -28.31 % - - -


Annual Roi Comment
In the fiscal year 2022 ROI improved to 33.49 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Laboratory Analytical Instruments Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
OMIC's Roi Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Return On Investment for OMIC's Competitors
Roi for Singular Genomics Systems Inc's Suppliers
Return On Investment for OMIC's Customers

Other Ratios
OMIC's Roa OMIC's Inventory Turnover Ratio OMIC's Growth Rates OMIC's Dividend Statistics
OMIC's Profitability Ratios OMIC's Asset Turnover Ratio OMIC's Dividend Growth
OMIC's Roe OMIC's Valuation Ratios OMIC's Financial Strength Ratios OMIC's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Harpoon Therapeutics Inc   91.85 %
Scynexis Inc   79.06 %
Science 37 Holdings Inc   78.20 %
Biomx Inc   76.77 %
Tenax Therapeutics Inc   68.79 %
Avalo Therapeutics Inc   67.67 %
Ocuphire Pharma Inc   65.54 %
Dariohealth Corp   57.65 %
Cv Sciences Inc   54.14 %
Entera Bio Ltd   50.91 %
Janone Inc   50.29 %
Star Equity Holdings Inc   44.80 %
Elite Pharmaceuticals Inc   44.12 %
Idexx Laboratories Inc  43.85 %
Zymeworks Inc   39.50 %
Medpace Holdings Inc   38.76 %
Mei Pharma Inc   38.41 %
Enzo Biochem Inc  38.07 %
Malachite Innovations Inc   37.82 %
Mettler toledo International Inc   37.29 %
Cortexyme Inc   36.76 %
Fusion Pharmaceuticals Inc   35.64 %
Singular Genomics Systems Inc   31.10 %
Semler Scientific Inc   30.96 %
National Research Corporation  30.72 %
Synaptogenix Inc   30.24 %
Denali Therapeutics Inc   29.23 %
Shockwave Medical Inc   28.94 %
Vaso Corporation  28.94 %
Arcturus Therapeutics Holdings Inc   28.09 %


Date modified: 2023-11-16T18:32:53+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com